Cara Therapeutics' Stock Buoyed By Positive Korsuva Data For Post-Op Pain

 
• By Sten Stovall
  
Laparoscopic equipment
Phase II/III Korsuva trial met its primary endpoint in patients undergoing abdominal surgeries • Source: Shutterstock

More from Clinical Trials

More from R&D